$APDN News

Last published 1y ago

1y agoAPDNApplied DNA Sciences to Begin Trading Under New Ticker 'BNBX' Reflecting Digital Asset Treasury StrategyBusiness WireTicker changing from ‘APDN' to ‘BNBX' effective October 7, 2025 Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company advancing a yield focused BNB digital asset treasury
1y agoAPDNApplied DNA Sciences Announces Private Placement of Up To $58 Million To Initiate BNB Treasury Strategy and BNB Native Yield GenerationBusiness WireAppoints TradFi and DeFi Leaders as Advisers, Including Anthony Scaramucci
1y agoAPDNApplied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry ConferencesACCESS NewswireSTONY BROOK, NY / ACCESS Newswire / September 23, 2025 / Applied DNA Sciences, Inc. , a biotechnology company focused on providing nucleic acid production
1y agoAPDNApplied DNA Reports Third Quarter Fiscal 2025 Financial ResultsACCESS NewswireSTONY BROOK, NY / ACCESS Newswire / August 14, 2025 / Applied DNA Sciences, Inc. , a biotechnology company focused on providing nucleic acid production
1y agoAPDNApplied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic ApplicationACCESS NewswireSTONY BROOK, NY / ACCESS Newswire / July 24, 2025 / Applied DNA Sciences, Inc. , a leader in synthetic DNA manufacturing powered by scalable PCR
1y agoAPDNApplied DNA Regains Compliance with All Nasdaq Continued Listing RequirementsACCESS NewswireSTONY BROOK, NY / ACCESS Newswire / July 7, 2025 / Applied DNA Sciences, Inc. , a leader in PCR-based DNA technologies, today announced that on July 2, 2025, it received written
1y agoAPDNApplied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRxACCESS Newswire- Conducts 27% Workforce Reduction, Ceases Operations at Applied DNA Clinical Labs, Positions LineaRx for Growth - STONY BROOK, NY / ACCESS Newswire / June 30, 2025 / Applied DNA Sciences, Inc. , a leader in
1y agoAPDNApplied DNA Announces Retirement of Chairperson and CEO Dr. James A. HaywardACCESS NewswirePresident and COO Judy Murrah Appointed New Chairperson of the Board of Directors and CEO STONY BROOK, NY / ACCESS Newswire / June 17, 2025 / Applied DNA Sciences, Inc. ("Applied DNA" or the
1y agoAPDNApplied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17ACCESS NewswireSTONY BROOK, NY / ACCESS Newswire / May 29, 2025 / Applied DNA Sciences, Inc. , a leader in polymerase chain reaction -based technologies, is
1y agoAPDNApplied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025ACCESS NewswireSTONY BROOK, NY / ACCESS Newswire / May 29, 2025 / Applied DNA Sciences, Inc. , a leader in PCR-based DNA technologies, today announced that it will
1y agoAPDNApplied DNA Reports Second Quarter Fiscal 2025 Financial ResultsACCESS Newswire- Therapeutic DNA Production Services Segment Revenues Up 44% Y/Y, Contributing to a 6% Increase in Total Revenues -- Intra-Quarter Investor Conference Call and Webcast Scheduled for June 3, 2025, at 4:30 PM ET
1y agoAPDNApplied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3ACCESS NewswireSTONY BROOK, NY / ACCESS Newswire / May 14, 2025 / Applied DNA Sciences, Inc. , a leader in polymerase chain reaction -based technologies, will
1y agoAPDNApplied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNAACCESS Newswire- Pivot to U.S.-based Supply Chain for Critical Input Materials Completed - STONY BROOK, NY / ACCESS Newswire / April 21, 2025 / Applied DNA Sciences, Inc. , a leader
1y agoAPDNApplied DNA Regains Compliance with Nasdaq Minimum Bid Price RequirementACCESS NewswireSTONY BROOK, NY / ACCESS Newswire / April 8, 2025 / Applied DNA Sciences, Inc. , a leader in PCR-based DNA technologies, today announced that on April 7, 2025, it received a notification letter
1y agoAPDNApplied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety AnnouncementACCESS Newswire- Company Revamps Pharmacogenomics Go-To-Market Strategy, Targets Validated PGx Assay Towards Specific Use Cases - STONY BROOK, NY / ACCESS Newswire / April 1, 2025 / Applied DNA Sciences, Inc. (Applied DNA
1y agoAPDNApplied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed TestACCESS NewswireSTONY BROOK, NY / ACCESS Newswire / March 26, 2025 / Applied DNA Sciences, Inc. , a leader in PCR-based DNA technologies, today announced that Applied DNA Clinical
1y agoAPDNApplied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025ACCESS NewswireSTONY BROOK, NY / ACCESS Newswire / March 12, 2025 / Applied DNA Sciences, Inc. , a leader in PCR-based DNA technologies, today announced that it will effect a
1y agoAPDNApplied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational ProgressACCESS Newswire- Announces Exit of DNA Tagging and Security Products and Services Business Segment -- Workforce Reduction of 20% of Headcount Implemented in January -- GMP Site 1 Facility Complete and Certified for Commercial Operation
1y agoAPDNApplied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025ACCESS NewswireInvestor Call and Webcast Scheduled for 4:30 P.M ET STONY BROOK, NY / ACCESS Newswire / February 12, 2025 / Applied DNA Sciences, Inc. , a leader in
1y agoAPDNApplied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14ACCESS NewswireSTONY BROOK, NY / ACCESS Newswire / February 11, 2025 / Applied DNA Sciences, Inc. , a leader in PCR-based DNA technologies, today issued a reminder to
1y agoAPDNApplied DNA Completes Buildout of GMP Facility for LineaDNA IVT TemplatesACCESS Newswire- Signals Start of New Commercialization Phase for LineaRx Subsidiary -- Company Negotiating GMP Supply Agreement -- Company Reaffirms Strategic Restructuring Timeline - STONY BROOK, NY / ACCESSWIRE / January 10, 2025 /
1y agoAPDNApplied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy CarterACCESS NewswireSTONY BROOK, NY / ACCESSWIRE / January 8, 2025 / Applied DNA Sciences, Inc. , a leader in polymerase chain reaction -based technologies, today
1y agoAPDNApplied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNAACCESS Newswire- Regulatory Approval Showcases Clinical Advancement of Linea DNA™ as a Rapid and Effective Means of Producing CAR-T cell Therapies -STONY BROOK, NY / ACCESSWIRE / December 18, 2024 / Applied DNA Sciences, Inc.
1y agoAPDNApplied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic MedicinesACCESS Newswire- Pursuing Divestiture of CertainT® Platform, Implements Changes to Corporate Leadership -- Build-out of GMP Manufacturing Facility to be Completed by January 9, 2025 -- Webcast and Conference Call Scheduled for
1y agoAPDNApplied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-outACCESS NewswireSTONY BROOK, NY / ACCESSWIRE / December 16, 2024 / Applied DNA Sciences, Inc. , a leader in polymerase chain reaction -based technologies, today
2y agoAPDNApplied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private PlacementACCESS NewswireSTONY BROOK, NY / ACCESSWIRE / October 30, 2024 / Applied DNA Sciences, Inc. , a leader in PCR-based DNA technologies, today announced the pricing of a
2y agoAPDNApplied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16ACCESS NewswireSTONY BROOK, NY / ACCESSWIRE / October 15, 2024 / Applied DNA Sciences, Inc. , a leader in PCR-based DNA technologies, today announced that Dr. James A. Hayward, president and chief
2y agoAPDNApplied DNA Regains Compliance with Nasdaq Minimum Bid Price RequirementACCESS NewswireSTONY BROOK, NY / ACCESSWIRE / September 18, 2024 / Applied DNA Sciences, Inc. , a leader in PCR-based DNA technologies, today announced that on September 17, 2024, it received a notification
2y agoAPDNApplied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 3rd Annual mRNA Process Development & Manufacturing SummitACCESS Newswire- Co-Hosts Seminar with mRNA CDMO Kudo Bio to Demonstrate Linea IVT Capability for Rapid mRNA Manufacturing - STONY BROOK, NY / ACCESSWIRE / September 17, 2024 / Applied DNA Sciences, Inc. , a
2y agoAPDNApplied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic ApplicationACCESS Newswire- Recurring and Accelerated Receipt of Order Reflects Customer Commitment to Linea DNA - STONY BROOK, NY / ACCESSWIRE / September 17, 2024 / Applied DNA Sciences, Inc. ("Applied DNA" or the
2y agoAPDNApplied DNA Launches Mpox Clade I and Clade II Testing ServiceACCESS NewswireSTONY BROOK, NY / ACCESSWIRE / September 11, 2024 / Applied DNA Sciences, Inc. , a leader in PCR-based DNA technologies, today announced that its wholly-owned clinical laboratory subsidiary,
2y agoAPDNApplied DNA Selected by LRQA for Isotopic Testing Pilot Project in PakistanACCESS Newswire- Pilot Project To Demonstrate Effectiveness of CertainT® for Cotton Textile Traceability - STONY BROOK, NY / ACCESSWIRE / September 4, 2024 / Applied DNA Sciences, Inc. , a leader in
2y agoAPDNApplied DNA Submits Validation Package to New York State Department of Health to Expand Linea Mpox Virus 1.0 Assay to Mpox Clade IACCESS Newswire-Validation Studies Confirmed the Assay Can Detect Mpox Clade I and Clade Ib in addition to Clade II- STONY BROOK, NY / ACCESSWIRE / August 23, 2024 / Applied DNA Sciences, Inc. , a
2y agoAPDNApplied DNA To Submit Application to New York State Department of Health to Expand Intended Use of Linea Mpox Virus 1.0 Assay to Mpox Clade IACCESS NewswireSTONY BROOK, NY / ACCESSWIRE / August 19, 2024 / Applied DNA Sciences, Inc. , a leader in PCR-based DNA technologies, today announced its intention to seek an expansion of the approved intended
2y agoAPDNApplied DNA Sciences, Inc. (APDN) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
2y agoAPDNApplied DNA Announces Third Quarter Fiscal Year 2024 Financial ResultsACCESS Newswire- Conference Call/Webcast Scheduled for Today at 4:30 PM ET - STONY BROOK, NY / ACCESSWIRE / August 8, 2024 / Applied DNA Sciences, Inc. , a leader in
2y agoAPDNApplied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024ACCESS NewswireSTONY BROOK, NY / ACCESSWIRE / August 7, 2024 / Applied DNA Sciences, Inc. , a leader in polymerase chain reaction -based technologies, today
2y agoAPDNCORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics SummitACCESS Newswire- This Version Removes the Use of 'Presentation' from the Prior-issued Headline -- Linea™ IVT Platform Delivers All The Benefits of Conventional IVT Without dsRNA Contamination - STONY BROOK, NY / ACCESSWIRE / July
2y agoAPDNApplied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Presentation Annual mRNA-based Therapeutics SummitACCESS Newswire- Linea™ IVT Platform Delivers All The Benefits of Conventional IVT Without dsRNA Contamination - STONY BROOK, NY / ACCESSWIRE / July 29, 2024 / Applied DNA Sciences, Inc. , a leader in
2y agoAPDNApplied DNA Enters into Multi-Year Commercialization Agreement with Indus Group for Large-Scale Implementation of CertainT Cotton TraceabilityACCESS Newswire- Indus Group Consumes Approximately 450 Million Pounds of Cotton Annually for the Manufacture of Apparel, Footwear, and Accessories for Global Brands and Retailers - STONY BROOK, NY / ACCESSWIRE / July 25, 2024 /
2y agoAPDNU.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation ContractACCESS NewswireSTONY BROOK, NY / ACCESSWIRE / July 18, 2024 / Applied DNA Sciences, Inc. , a leader in PCR-based DNA technologies, today announced that the U.S. Defense Logistics Agency exercised the
2y agoAPDN MRVIApplied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform EconomicsACCESS Newswire- Project Results in over 70% Reduction in Linea RNAP Manufacturing Cost to Yield a Material Improvement in Linea IVT Platform Profitability -- Applied DNA Secures Commercial Linea RNAP Quantity Sufficient to Support
2y agoAPDNApplied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) TestingACCESS NewswirePartnership Will Aid Physicians in Precision Prescribing Decisions Based on Applied DNA's TR8™ Pharmacogenomic Test STONY BROOK, NY / ACCESSWIRE / June 18, 2024 / Applied DNA Sciences, Inc.
2y agoAPDNApplied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of HealthACCESS NewswireSTONY BROOK, NY / ACCESSWIRE / June 13, 2024 / Applied DNA Sciences, Inc. , a leader in PCR-based DNA technologies, today announced that the New York
2y agoAPDNApplied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea(TM) IVT PlatformACCESS NewswirePatent covers the Composition of the Company's Proprietary Linea™ RNAP, a Core Technology Empowering the Linea™ IVT PlatformPatent Application Also Currently Pending in Key International Markets STONY BROOK,
2y agoAPDNApplied DNA Announces Pricing of $12 Million Public OfferingACCESS NewswireSTONY BROOK, NY / ACCESSWIRE / May 28, 2024 / Applied DNA Sciences, Inc. , a leader in PCR-based DNA technologies, today announced the pricing of a public
2y agoAPDNInstitute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of Applied DNA's Linea DNATM for the Non-Viral Manufacture of CAR T-Cell Therapy for Refractory AMLACCESS NewswireSTONY BROOK, NY / ACCESSWIRE / May 13, 2024 / Applied DNA Sciences, Inc. , a leader in PCR-based DNA technologies, and the Institute of Hematology and Blood Transfusion today
2y agoAPDNApplied DNA Announces Second Quarter Fiscal Year 2024 Financial ResultsACCESS NewswireSTONY BROOK, NY / ACCESSWIRE / May 10, 2024 / Applied DNA Sciences, Inc. , a leader in PCR-based DNA technologies, today announced consolidated financial
2y agoAPDNApplied DNA Regains Compliance with Nasdaq Minimum Bid Price RequirementACCESS NewswireSTONY BROOK, NY / ACCESSWIRE / May 10, 2024 / Applied DNA Sciences, Inc. , a leader in PCR-based DNA technologies, today announced that on May 9, 2024, it received a notification letter (the
2y agoAPDNApplied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development ProgramACCESS NewswireAward Seeks to Demonstrate Feasibility of Manufacturing mRNA Vaccines in Only 7 Days STONY BROOK, NY / ACCESSWIRE / April 25, 2024 / Applied DNA Sciences, Inc. , a leader in PCR-based DNA